Medrol Dose Pack for new concussion headache relief
Treatments studied
Part of Brain & nervous system, Injuries & trauma, Pain clinical trials.
This trial tests whether a Medrol “dose pack” (a short course of steroid medicine taken by mouth) can reduce acute headache pain after a concussion. It may help people whose concussion headaches are frequent and severe soon after injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older and can give informed consent (in person or by telehealth).
- Your concussion headache started after a diagnosed concussion, and you’re within 30 days of the injury.
- Your headache is at least 5 out of 10 in pain and lasts more than 4 hours per day.
- Your headache happens every day (not just some days), and began within 7 days after the concussion.
- You can take oral medicine and are willing to follow the study plan for the whole study.
- You do not have certain safety issues like brain bleeding on imaging, pregnancy, or steroid medicine contraindications/allergy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a carefully supervised exercise program can help people who still have headaches or other symptoms weeks after a mild head injury. If you get symptoms when you try to be active, this study may offer a structured way to help you recover.
This study tests whether a non-invasive magnetic pulse treatment (repetitive transcranial magnetic stimulation) can help people with long-lasting headaches following a mild concussion. If you are 18 to 55 years old and have had daily headaches for at least 3 months after your head injury, this study may help find a new way to relieve your pain.
This trial compares two IV pain relievers—metoclopramide and acetaminophen—given in the emergency department to see which works better for treating concussion pain. If you qualify, you may receive one of these medications to help with your symptoms.
This trial tests a steroid medicine called methylprednisolone to see if it can help people who have had a moderate to severe brain injury. It aims to reduce swelling in the brain and possibly improve recovery.
This nasal spray study tests a new drug (ONP-002) given soon after a mild concussion to see if it is safe and helps with recovery. The study also checks how the drug moves through the body and how it affects certain brain markers.
This trial tests whether people with long-term headache after a mild head injury have an abnormal reaction to a substance called adrenomedullin, which may play a role in causing headaches. You will receive adrenomedullin and a placebo in separate sessions to see how your headache responds.
Hear when a new Post-Concussion Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.